US Biologic/CAES Report Field Trials of Orally Delivered Anti-Lyme Vaccine Targeting the Field Mouse

The Connecticut Agricultural Experiment Station (CAES) and US Biologic announced the publication of field trials showing the effectiveness of the delivery of an orally-delivered anti-Lyme vaccine targeting the major wildlife source of Lyme disease, the white-footed mouse.